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We report a new approach to preoperative vascular exclusion of a carotid body tumor. Before surgery, covered stents were
placed in the external carotid artery, resulting in vascular exclusion of the tumor. Subsequent surgical excision was
uneventful, with operative blood loss less than 200 mL and no neurologic complications postoperatively. This technique
deserves further consideration as a reasonable alternative to conventional embolization. (J Vasc Surg 2003;38:389-91.)
Carotid body tumors, also known as paragangliomas or
chemodectomas, are uncommon neoplasms that arise at
the carotid bifurcation.1 When these tumors are discov-
ered, resection is generally recommended. Historically,
however, mortality and morbidity were high with resec-
tion.2,3 Recent advances have reduced operative mortality
associated with these tumors, but morbidity associated with
resection has remained high in many series.2-5 Preoperative
embolization decreases morbidity associated with carotid
body tumor resection, although its use has been controver-
sial because of potential for procedure-related stroke.2,4,5
We report a new approach to preoperative vascular exclu-
sion of carotid body tumor.
CASE REPORT
A 62-year-old woman had transient left facial numbness, along
with drooling and dysarthria, but within 2 hours the symptoms
resolved. Medical history was significant for congestive heart fail-
ure, diabetes mellitus, and hypertension. She was taking benaz-
epril, atorvastatin, isosorbide nitrate, clopidogrel, and digoxin. At
initial presentation, results of neurologic examination were nor-
mal; a fixed nontender mass was noted in the left cervical region,
and a carotid bruit on the left was appreciated. Results of clinical
examination were otherwise unremarkable. A computed tomogra-
phy scan of the head revealed an old right-sided basal ganglia
infarct, but no acute neuroanatomic findings.
The patient was admitted, and intravenous heparin therapy
was started. The next day, a magnetic resonance image confirmed
no new acute neurologic process. A cervical duplex ultrasound scan
revealed a fixed mass at the left carotid bifurcation, splaying the
internal and external carotid arteries. Flow velocity in both the left
external and internal carotid arteries exceeded 280 cm/s. Arteriog-
raphy was performed, which revealed a highly vascularized mass,
approximately 4 cm in diameter (Fig 1). There was no angio-
graphic evidence of arterial stenosis. Transesophageal echocardi-
ography was performed, which revealed a patent foramen ovale.
One week after presentation the patient underwent percutaneous
closure of the patent foramen ovale. Subsequently, two covered
stents (Jostent; JOMED,Helsingborg, Sweden) were placed in the
proximal external carotid artery: a 5 mm stent distally and a 7 mm
stent proximally. This procedure was accomplished in 48 minutes,
and resulted in exclusion of multiple feeding branches of the
tumor, with preservation of most of the major branches of the
external carotid artery (Fig 2). The patient tolerated the procedure
well, without complication. The next day the carotid body
tumor was resected, with estimated intraoperative blood loss
less than 200 mL. The stented external carotid artery presented
no technical difficulties. The patient awoke neurologically in-
tact, and was discharged to home on the second postoperative
day. Findings at final histologic analysis were consistent with
paraganglioma.
DISCUSSION
Initial reports of operative resection of carotid body
tumors were significant for increased mortality, substantial
morbidity including stroke and cranial nerve injury, and
surgical blood loss often in excess of 2 L.1-3 Subsequent
advances in preoperative evaluation, anesthetic manage-
ment, and intraoperative handling of these tumors have
resulted in decreased mortality from extirpation of carotid
body tumors.2-5 Indeed, operative resection is now recom-
mended for carotid body tumors whenever they are identi-
fied. More controversial has been preoperative emboliza-
tion of these tumors.2-5 As evidenced in the Table (online
only), preoperative embolization results in dramatic reduc-
tion in intraoperative blood loss at resection of carotid body
tumors (Shamblin classifications II and III6). However,
preoperative embolization is not without risk, particularly
for central nervous system injury.2,4,5 The true incidence of
procedure-related stroke when embolization of carotid
body tumors is performed is difficult to determine, because
of the low numbers of these procedures performed in
individual institutions and potential for underreporting of
results; however, in many series the incidence of stroke
exceeds 10%.5,7,8 Covered stents have been used as an
alternative to embolization when it was believed advanta-
From the Cardiovascular Institute of the South and Terrebonne General
Medical Center.
Additional material for this article may be found online at www.mosby.
com/jvs.
Reprint requests: Henry F. Tripp, Jr, MD, Cardiovascular Institute of
the South, 611 Liberty St, Houma, LA 70360 (e-mail: Henry.Tripp
@cardio.com).
Copyright © 2003 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2003/$30.00  0
doi:10.1016/S0741-5214(03)00140-X
389
Fig. 1. Preoperative arteriogram of carotid artery bifurcation showing highly vascularized carotid body tumor.
Fig. 2. After vascular exclusion with covered stents, there is markedly diminished vascularity of the tumor.
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geous in reducing risk for distal embolization, as in closure
of renal arteriovenous fistulas.9
The technique we report, preoperative vascular exclu-
sion with use of covered stents, may have advantages over
traditional methods of embolization. As with embolization,
vascular exclusion with covered stents results in reduced
intraoperative blood loss. Incomplete occlusion is pre-
vented with covered stent exclusion, and, theoretically,
small nutrient branches that may not be apparent on angio-
grams are more likely to be excluded with a covered stent;
inflow from collateral vessels, however, may persist. In
addition, there is thought to be a lower risk for stroke with
this technique compared with conventional preoperative
embolization, because there no coils or intra-arterial gel
foam are used, which can flow inadvertently into the inter-
nal carotid artery and presumably lead to stroke. Finally, the
technique we report is technically simple and averts the
time-consuming process of individual identification of nu-
trient arteries, cannulation, and slow injection of occluding
agents necessary for successful embolization; therefore this
technique may be less challenging, even for experienced
interventionalists.5,7,8
REFERENCES
1. Krupski WC, Effeney DJ, Ehrenfeld WK, Stoney RJ. Cervical chemod-
ectoma: technical considerations and management options. Am J Surg
1982;144:215-20.
2. LaMuraglia GM, Fabian RL, Brewster DC, Pile-Spellman J, Darling C,
Cambria RP, et al. The current surgical management of carotid body
paragangliomas. J Vasc Surg 1992;15:1038-45.
3. Hallet JW, Nora JD, Hollier LH, Cherry KJ, Pairolero PC. Trends in
neurovascular complications of surgical management for carotid body
and cervical paragangliomas: a fifty-year experience with 153 tumors. J
Vasc Surg 1988;7:284-91.
4. Westerbrand A, Hunter GC, Cintora I, Coulthard SW, Hinni ML,
Gentile AT, et al. Current trends in the detection and management of
carotid body tumors. J Vasc Surg 1998;28:84-93.
5. Persky MS, Setton A, Yasunari N, Hartman J, Frank D, Berenstein A.
Combined endovascular and surgical treatment of head and neck paran-
gliomas: a team approach. Head Neck 2002;24:423-31.
6. Shamblin WR, ReMine WH, Sheps SG, Harrison EG. Carotid body
tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J
Surg 1971;122:732-9.
7. Kafie FE, Freischlag JA. Carotid body tumors: the role of preoperative
embolization. Ann Vasc Surg 2001;15:237-42.
8. Robison JG, Shagets FW, Beckett WC, Spies JB. A multidisciplinary
approach to reducing morbidity and operative blood loss during resec-
tion of carotid body tumors. Surg Gynecol Obstet 1989;168:166-70.
9. Sprouse LR, Hamilton IN. The endovascular treatment of a renal
arteriovenous fistula: placement of a covered stent. J Vasc Surg 2002;
36:1066-8.
10. Plukker JT, Brongers EP, Vermey A, Krikke A, van den Dungen JJ.
Outcome of surgical treatment for carotid body paraganglioma. Br J
Surg 2001;88:1382-6.
11. Liapis CD, Evangelidakis EL, Papavassiliou VS, et al. Role of malig-
nancy and preoperative embolization in the management of carotid
body tumors. World J Surg 2000;24:1526-30.
12. Wang SJ, Wang MB, Barauskas TM, Calcaterra TC. Surgical manage-
ment of carotid body tumors. Otolaryngol Head Neck Surg 2000;123:
202-6.
13. Murphy TP, Brackman DE. Effects of preoperative embolization on
glomus jugulare tumors. Laryngoscope 1989;99:1244-7.
Submitted Dec 17, 2002; accepted Jan 30, 2003.
Additional material for this article may be found online
at http://www.mosby.com/jvs.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 2 Tripp et al 391
Online only. Effect of preoperative embolization on average blood loss during surgical resection of carotid body
tumors*
Study Year No. of patients
Shamblin
classification
Average blood
loss (mL)
No preoperative embolization
Plukker et al10 2001 8 III 2200
Liapis et al11 2000 11 II, III 700
Wang et al12 2000 Not stated II 1233
LaMuraglia et al2 1992 8 Not stated 609
Murphy and Brackman13 1989 13 II, III 2715
Preoperative embolization
Kafie and Freischlag7 2001 2 II 200
Liapis et al11 2000 3 II, III 400
Wang et al12 2000 Not stated II 430
LaMuraglia et al2 1992 11 Not stated 372
Robison et al8 1989 5 Not stated 332
Murphy and Brackman13 1989 13 II, III 1122
*Data from published reports. After a thorough PubMed search for the term “Carotid body tumor,” articles were selected on the basis of the following criteria:
recent publication, ie, within 15 years; more than 1 patient; detailed information on size or Shamblin classification of resected tumors (in all series noted, tumors
were Shamblin class II or III); detailed information on blood loss. As can be seen, preoperative embolization is associated with dramatic reduction in operative
blood loss in these recent series.
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